RetinalGenix Technologies (RTGN) Gains from Investment Securities (2020 - 2026)

RetinalGenix Technologies has disclosed Gains from Investment Securities across 7 years of filings, most recently posting $165375.0 for Q1 2026.

• Gains from Investment Securities for Q1 2026 came in at $165375.0, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $643876.0 (up 301.76% YoY), and the FY2025 annual result was $1.6 million, down 32.3% from the prior year.
• Gains from Investment Securities came in at $165375.0 for Q1 2026 at RetinalGenix Technologies, roughly flat from $165375.0 in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of $2.5 million in Q1 2024 to a low of -$1.1 million in Q4 2023.
• The 5-year median for Gains from Investment Securities is $790000.0 (2025), against an average of $1.2 million.
• Across the five-year window, Gains from Investment Securities surged 2760.61% in 2022 and slumped 339.75% in 2023, its largest moves.
• RetinalGenix Technologies' Gains from Investment Securities stood at $452433.0 in 2022, then plunged by 339.75% to -$1.1 million in 2023, then soared by 113.62% to $147751.0 in 2024, then grew by 11.93% to $165375.0 in 2025, then changed by 0.0% to $165375.0 in 2026.
• The last three Gains from Investment Securities figures came in at $165375.0 (Q1 2026), $165375.0 (Q4 2025), and $790000.0 (Q3 2025), per Business Quant data.